World Immunotherapy Congress 2017
The congress brings together experts to discuss immune checkpoint inhibitors and cell therapy with a focus on some exciting customisations such as CAR-T and Oncolytic Viral Immunotherapy.
Immunotherapy currently offers the brightest hope for cancer treatment. New developments with checkpoint inhibitors and co-stimulatory targets have enabled some stunning breakthroughs and high optimism for the sector. Recently, there have been some incredibly exciting new therapies in areas such as CAR-T and Oncolytic Viral Immunotherapy.
Our vision is to bring together the full community and provide a single meeting point for the whole value chain. It is where science meets business to make immunotherapy the cornerstone of the fight against cancer.
After a first successful edition, the World Immunotherapy Congress will once again bring leading clinicians, pharmaceutical companies, biotechs and research institutes together, and will take place alongside the flagship European Antibody Congress, as well as the World Biosimilar Congress and the World HPAPI Congress.
On Tuesday October 31, 2017 at 8:00 am (ends Thursday November 2, 2017 at 6:00 pm)
Category: Conferences - Science, Health & Medicine - Pharmaceuticals - Clinical
Final standard price : EUR 3160
Final academic price : EUR 1580
Venue: Congress Center Basel, Congress Center Basel, Messeplatz 21, 4058 Basel, Switzerland, 4005 BASEL